Anti-LGI1–associated cognitive impairment

Cognitive impairment

Cognitive impairment

? Multiple Choice Questions Section The Neurosciences Journal includes this section of multiple choice questions as part of its commitment to continuous education and learning in Neurosciences. Experts in various neuroscience specialties are invited to participate with their knowledge and expertise in this section. Neurology, neurosurgery, and other board residents are encouraged to read this s...

Dexmedetomidine attenuates isoflurane-induced cognitive impairment through antioxidant, anti-inflammatory and anti-apoptosis in aging rat.

As a kind of α2 adrenergic receptor agonists, dexmedetomidine generates sedation, anti-anxiety and anesthesia effects by hyperpolarizing noradrenergic nerve cells in locus coeruleus. This study was designed to investigate the neuroprotective of dexmedetomidine attenuates isoflurane-induced cognitive impairment, and the possible underlying mechanism in aging rat. Firstly, we used isoflurane-indu...

Vascular cognitive impairment.

Dementia, a syndrome of declining higher cognitive functioning, found in approximately 10 per cent of adults 65 years and older, and 50 per cent of adults older than 90 years. Alzheimer’s disease (AD) accounts for 50 to 80 per cent of all dementing illnesses. Vascular dementia comprises 15 to 20 per cent of dementia and in some clinico-pathological series is the second commonest form of dementi...

Diabetes and Cognitive Impairment

Dr. José A. Luchsinger is Associate Professor of Medicine and Epidemiology, Columbia University Medical Center, New York, NY. Dr. Christopher Ryan is Director, Human Research Protection Program, University of California San Francisco, San Francisco, CA. Dr. Lenore J. Launer is Senior Investigator and Chief, Neuroepidemiology Section, Laboratory of Epidemiology and Population Sciences, National ...